AU8329391A - Stable doxorubicin/liposome composition - Google Patents

Stable doxorubicin/liposome composition

Info

Publication number
AU8329391A
AU8329391A AU83293/91A AU8329391A AU8329391A AU 8329391 A AU8329391 A AU 8329391A AU 83293/91 A AU83293/91 A AU 83293/91A AU 8329391 A AU8329391 A AU 8329391A AU 8329391 A AU8329391 A AU 8329391A
Authority
AU
Australia
Prior art keywords
liposome composition
doxorubicin
stable
stable doxorubicin
liposome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU83293/91A
Other languages
English (en)
Inventor
Robert Abra
Anthony Hei-Leung Huang
Richard E. Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Liposome Technology Inc
Original Assignee
Liposome Technology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Technology Inc filed Critical Liposome Technology Inc
Publication of AU8329391A publication Critical patent/AU8329391A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU83293/91A 1990-08-08 1991-08-02 Stable doxorubicin/liposome composition Abandoned AU8329391A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56407090A 1990-08-08 1990-08-08
US564070 1990-08-08

Publications (1)

Publication Number Publication Date
AU8329391A true AU8329391A (en) 1992-03-02

Family

ID=24253045

Family Applications (1)

Application Number Title Priority Date Filing Date
AU83293/91A Abandoned AU8329391A (en) 1990-08-08 1991-08-02 Stable doxorubicin/liposome composition

Country Status (5)

Country Link
EP (1) EP0543871A1 (fr)
JP (1) JPH06502623A (fr)
AU (1) AU8329391A (fr)
CA (1) CA2088975A1 (fr)
WO (1) WO1992002208A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU700833B2 (en) * 1991-12-02 1999-01-14 Merial Medicinal products and pure preparations of melarsomine dihydrochloride, process for obtaining them and intermediate products obtained
BE1006379A3 (fr) * 1992-11-26 1994-08-09 Raymond Gilles Procede de conservation de cellules vivantes, d'ensembles de cellules et/ou de derives de ces cellules par lyophilisation.
ES2072223B1 (es) * 1993-11-25 1996-03-16 Lipotec Sa Liposomas encapsulando doxorubicina.
ES2186484B1 (es) 2000-10-10 2004-07-01 Lipotec, S.A. Liposomas encapsulando farmacos anticancerosos y uso de los mismos en el tratamiento de tumores malignos.
ES2708851T3 (es) 2006-10-06 2019-04-11 Bionet Pharma Gmbh Un implante del núcleo pulposo espinal
PL226015B1 (pl) 2011-03-03 2017-06-30 Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Liposomowy preparat zawierajacy przeciwnowotworowa substancje aktywna, sposob jego wytwarzania i zawierajaca go kompozycja farmaceutyczna

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4927571A (en) * 1987-05-18 1990-05-22 Liposome Technology, Inc. Preparation of injectable doxorubicin/liposome suspension

Also Published As

Publication number Publication date
CA2088975A1 (fr) 1992-02-09
EP0543871A1 (fr) 1993-06-02
WO1992002208A1 (fr) 1992-02-20
JPH06502623A (ja) 1994-03-24

Similar Documents

Publication Publication Date Title
AU7227491A (en) Mouthrinse composition
AU8600291A (en) Cosmetic composition
AU7731991A (en) Bleaching composition
AU7724591A (en) Bleaching composition
AU7199591A (en) Antimicrobial composition
AU9015891A (en) Animation
AU2212192A (en) Cosmetic composition
AU8021191A (en) Cosmetic composition
AU7086891A (en) Cosmetic composition
AU8554691A (en) Improved formulations
AU7118591A (en) Photochromic composition
AU1829992A (en) Cosmetic composition
AU5195090A (en) Liposome compositions
AU2888292A (en) Toiletries composition
AU3029992A (en) Cosmetic composition
AU6215190A (en) Shampoo composition
AU6991591A (en) Mixer
AU8764191A (en) Ibuprofen-antihistamine combinations
AU2818792A (en) Cosmetic composition
AU648841B2 (en) Cosmetic composition
AU8030591A (en) Cosmetic composition
AU1093992A (en) Cosmetic composition
AU3001889A (en) Antimicrobial soap composition
AU5316890A (en) Composition
AU7928191A (en) Compositions